Skip to content

Medicine that’s
RIGHT FOR OUR PATIENTS

Azurity specializes in providing safe, high-quality treatments for patients requiring customized formulations for their care.

Medicine that’s
RIGHT FOR OUR PATIENTS

Azurity specializes in providing safe, high quality treatments for patients requiring customized formulations for their care. Azurity focuses on the needs of patients, such as children and the elderly, requiring customized, user-friendly drug formulations.

Medicine that’s
RIGHT FOR OUR PATIENTS

Azurity specializes in providing safe, high quality treatments for patients requiring customized formulations for their care. Azurity focuses on the needs of patients, such as children and the elderly, requiring customized, user-friendly drug formulations.

The health and safety of our employees, patients, partners, and extended community is our top priority.   Read about our response to COVID-19.

Medicine That’s Easy to Give…
and to Take

Azurity’s products have benefited millions of patients who are unable to swallow conventional oral dosage forms, such as tablets and capsules, and whose needs are not served by other commercially available therapies.

Azurity currently offers a comprehensive product portfolio that serves multiple therapeutic areas, with more on the way!

FDA-APPROVED PRODUCTS

A growing portfolio of products designed to fulfill unmet needs of both pediatric and elderly patients.

FDA_Products_AZ

Labels for representation purposes only

NON-FDA APPROVED FIRST® COMPOUNDING KITS

A family of prescription compounding kits designed as an alternative to conventional dosage forms.

Labels for representation purposes only

Pharmacist to Pharmacist

Click below to access our USP RESOURCES TOOLKIT to help you navigate the ever-changing <795>, <797>, and <800> USP chapters.

News & Events

Azurity Pharmaceuticals Announces Three New Neurology Products

WOBURN, Mass. (February 8, 2021) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, announced today the purchase of the neurology portfolio from Eton Pharmaceuticals. The product portfolio includes lamotrigine (ET-105), zonisamide...

read more

Katerzia™, the First and Only Amlodipine Oral Suspension, 1 mg/mL, is Now Commercially Available for Pediatric Patients 6 Years of Age and Older

WOBURN, Mass. (September 25, 2019) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, announced today that Katerzia (amlodipine) Oral Suspension, 1 mg/mL, the first and only FDA-approved amlodipine oral suspension, is now commercially...

read more